Please login to the form below
CRO
This page shows the latest CRO news and features for those working in and with pharma, biotech and healthcare.
MSD hangs ‘for sale’ sign on French facility, shedding 207 staff
Back in 2015, MSD said it was in discussions with an unnamed contract research organisation (CRO) about a possible sale that never came through, and this week it reiterated its hope
Latest news
-
Syneos Health announces partnership with AiCure
Syneos Health’s scale as a leading global CRO, and the largest contract commercial organisation, will enable valuable customer engagements and expands our reach with biopharmaceutical companies of all sizes,”
-
Skills shortage and Brexit will hit R&D, warns UK pharma
The survey of 56 respondents across 30 different pharma and CRO companies, which revealed concerned about a shortfall in candidates across STEM subjects, but especially in a number of key
-
AI specialist Exscientia buys Kinetic Discovery
Kinetic operates mainly as a contract research organisation (CRO) at present, providing services such as hit identification, confirmation and validation.
-
Geron poleaxed as partner J&J abandons only pipeline drug
He also noted that the company has hired a contract research organisation (CRO) to help ensure IMerge and an extended IMbark trial can continue without interruption.
-
New industry standards group launched
Henry Levy, president of Align Clinical CRO, said: “There’s tremendous potential to enhance clinical trial execution through common technology standards that will benefit the entire industry. ... Align Clinical CRO represents an important industry
More from news
Approximately 34 fully matching, plus 70 partially matching documents found.
Latest Intelligence
-
Unlocking the potential of data sharing
For clinical trials, this means the GDPR governs the trial activities of all UK/EU subjects, as well as all local and foreign pharma companies and clinical research organisations (CRO), acting
-
Transforming clinical trials to accelerate drug development
As director of operations at a CRO, it is my job to focus on the commercial management of the studies we perform and to constantly evaluate whether the processes we undertake
-
How early-stage clinical research is facilitating the new wave of personalised medicines
Designing studies for gene therapies is not simply ‘business as usual’ for contract research organisations (CRO) and clinical investigators.
-
The lessons learned from COVID-19’s impact on oncology trials
Dave Espenshade is Vice President of CRO Partnerships, Greenphire. 25th May 2021.
-
Transforming clinical trial data into a long-term asset
of CRO respondents admitted to being unable to convert documents from multiple eClinical applications used in the course of a trial.
More from intelligence
Approximately 1 fully matching, plus 17 partially matching documents found.
Latest appointments
-
New faces at creative digital agency earthware
Prior to joining earthware, Charles held responsibility for the marketing activities at Domainex, a drug-discovery CRO.
-
Metrion Biosciences adds to its board
Barry’s substantial experience of drug discovery deal-making will be of great value to Metrion as we continue to build our worldwide CRO and collaboration business, and Andy’s dedication
-
Lynn Lewis joins Envigo
She becomes the CRO’s senior vice president of global sales. Envigo, a contract research organisation, has appointed Lynn Lewis to the position of senior vice president of global sales, a
-
Remi Gauchoux joins Carenity
Gauchoux has a 20-year international experience in healthcare and the CRO industries with expertise in late phase and real-world evidence analysis. ... His career has seen him work for Mapi Group, where he held the role of senior director in global
-
Dr Martine Dehlinger-Kremer becomes EUCROF president
Dr Dehlinger-Kremer has over 30 years of clinical research industry experience and currently serves as vice president for global medical and regulatory affairs at San Diego, US-based CRO SynteractHCR.
More from appointments
Approximately 12 fully matching, plus 54 partially matching documents found.
Latest from PMHub
-
SCIRIS ANNOUNCES APPOINTMENT OF NEW CEO
Isaac has a well-established healthcare industry pedigree, including roles across clinical research, sales and marketing within pharma and CRO companies, along with a 20-year career as a healthcare communications
-
Genetic Digital
Solutions for:. Pharmaceutical, biotech &CRO/CRM firms. Medical device manufacturers. Private healthcare providers.
-
Healthcare tech: the driving force behind value-based care?
Pharmaceutical companies and contract research organizations (CRO) are now adopting this platform technology at a lightning pace.
-
Carenity - ELSE CARE SAS
ELSE CARE SAS is digital CRO that could generate patients' insights through its direct-access to patient platform Carenity, allowing Real World Evidence generation for non interventional study at each step
-
Are patient recruitment and retention rates rising or falling?
The Tufts Center for the Study of Drug Development (CSDD) collected data on 87 clinical trials from four top-20 pharma companies and one global CRO, comparing the 2019 metrics from
More from PMHub
Approximately 1 fully matching, plus 27 partially matching documents found.
Subscribe to our email news alerts
-
Pharmacovigilance Manager
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- Highly competitive salary
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- MHRA to introduce new UK clinical trials framework
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- 2023 PM Society Awards – winners announced
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- Putting Skin in the Game at AAD 2023
- FDA proposes improvements for oncology clinical trials supporting accelerated approval
- NHS England announces rare genetic disorder fast-tracking service
- NICE sees ‘promise’ in four UTI tests that could help in fight against AMR
- Connectome competitiveness
- Humancomms for humancare?
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Trust me, I’m from pharma
- Sobi’s Kineret granted FDA Emergency Use Authorisation for COVID-19 related pneumonia
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- Genmab hires first chief operating officer
PMHub
M3 (EU)
M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors...
Latest intelligence
- Humancomms for humancare?
- Paul Hutchings, founder of fox&cat, writes on the role of humour in healthcare comms: PharmaComms 2023...
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
